Recent advances in biotechnology in areas as diverse as agriculture, the environment, food, and healthcare have led to much debate and media attention. This unique reference resource for advanced high school students and teachers explores the science behind these new technologies and examines the stakeholders and their stakes in the various debates. The author presents views of scientists, doctors, insurance companies, and big businesses, among others, on such issues as genetic testing, patenting of human gene sequences, cloning, and genetically engineered food.

Each chapter addresses a specific issue with the goals of helping readers understand all the different ways biotechnology is being explored and implemented in our lives today, as well as to critically perceive the arguments being made concerning these issues. Students will learn there is more to biotechnology than cloning sheep, that it is also used for such purposes as making cheese and beer. Each topic is presented as a Case Study describing of a range of technologies and a diversity of stakeholders that will allow users to draw their own conclusions. This introduction to the technologies and the debates surrounding them also encourages students to take advantage of the many available sources for further research, particularly on the Internet.

Today, most people use prescription medications. Every year, the multi-billion dollar pharmaceutical industry produces new medicines that treat everything from arthritis to AIDS, from high cholesterol to depression. But, despite recent controversies regarding the safety of drugs, consumers know little about the medications that they ingest and inject. How are these new medicines invented? How do consumers know that drugs are safe and effective? How are they tested? Who regulates their production - and who watches the regulators? How do drug companies produce the vast quantities needed for the marketplace, and why do they market their drugs as they do? The New Medicines leads the reader through the maze of the modern drug industry - from bench to bedside - and provides consumers with a step-by-step understanding of how new medicines are created, approved, marketed, and sold. In addition to explaining how drugs reach the medicine cabinet, the author - an experienced researcher and teacher - provides the scientific and business background for understanding the current controversial issues surrounding new medicines, such as:

• The rise and fall of the COX-2 inhibitors, Vioxx and Celebrex, and the process by which they were invented, approved, and re-evaluated.
• The saga of the cancer drug Erbitux and its creator, the company Imclone, made famous as the centerpiece of the Martha Stewart insider-trading scandal
• The strengths and weaknesses of the approval process of the Food and Drug Administration
• The controversial new marketing techniques of the pharmaceutical industry

A balanced work that provides readers with an unbiased look at the drugindustry, The New Medicines will answer the questions of anyone who has ever looked at a bottle of their prescription pills and wondered, "how did that get here?"